慢性粒细胞白血病(慢粒)是我国常见类型白血病之一.80%的病人经过大约1～5年的稳定期后发生急变而死亡。阻止或延缓、早期识别和及时合理治疗慢粒急变是仍需研究的课题。为此,对我们诊治的30例慢粒急变患者的资料进行分析,旨在探讨适于基层的诊断标准等问题。临床资料一、一般资料男20例、女10例。年龄20～62岁。稳定期均曾用过马利兰和/或靛玉红等药物;确诊慢粒至急变历时4～108个月、中数38个月,其中稳定期仅单用靛玉红治疗的8例平均56.5个月,中数 Chronic myelogenous leukemia (CML) is one of the most common leukemias in our country, and 80% of patients die after a period of about 1 to 5 years of stabilization. Preventing or delaying, early identification and timely and reasonable treatment of chronic ciliary mutagenesis is still a subject to be studied. To this end, we analyzed the data of 30 patients with CML, aimed at exploring the diagnostic criteria for the grass-roots level and other issues. Clinical data First, the general information 20 males and 10 females. Age 20 ~ 62 years old. Stable period have been used drugs such as Maryland and / or indirubin; Cochlear to emergency diagnosis of lasted 4 to 108 months, a median of 38 months, of which stable only with indirubin alone in 8 cases, an average of 56.5 Month, in the number